DANTRIUM CAPSULES 25 MG
DANTROLENE SODIUM : 25 MG · DIN 01997602 · ENDO OPERATIONS LTD.
Health Canada status: MARKETED
What is DANTRIUM CAPSULES?
DANTRIUM CAPSULES 25 MG contains DANTROLENE SODIUM : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 01997602, held by ENDO OPERATIONS LTD., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 27-Jan-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01997602 |
|---|---|
| Brand name | DANTRIUM CAPSULES |
| Generic / active ingredient | DANTROLENE SODIUM : 25 MG |
| Manufacturer | ENDO OPERATIONS LTD. |
| Strength | 25 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M03CA01 DANTROLENE |
| AHFS class | 12:20.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Jan-2026 |
| Original market date | 1993-12-31 00:00:00 |
Is DANTROLENE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by HIKMA CANADA LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code M03CA01 DANTROLENE. 3 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DANTRIUM INTRAVENOUS | 20 MG | POWDER FOR SOLUTION | ENDO OPERATIONS LTD. | MARKETED | DIN 01997572 |
| DANTROLENE SODIUM FOR INJECTION, USP | 20 MG | POWDER FOR SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02529998 |
| DANTRIUM CAP 100MG | 100 MG | CAPSULE | NORWICH EATON CANADA INC. | CANCELLED POST MARKET | DIN 00452521 |
| DANTRIUM CAP 25MG | 25 MG | CAPSULE | NORWICH EATON CANADA INC. | CANCELLED POST MARKET | DIN 00452513 |
| DANTRIUM CAPSULES | 100 MG | CAPSULE | PAR PHARMACEUTICAL COMPANIES | CANCELLED POST MARKET | DIN 01997653 |
Who else supplies DANTROLENE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DANTROLENE appears in 6 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.